Alterations in the mesenchymal epithelial transition (MET) gene, encoding a tyrosine kinase receptor, are frequently observed in NSCLC, with MET exon 14 skipping mutations leading to increased receptor activity [25]. This evidence concerns the gene MET and non-small cell lung carcinoma.